XML 113 R10.htm IDEA: XBRL DOCUMENT
v3.25.0.1

BALANCE SHEET COMPONENTS | 12 Months Ended
--- | ---
Dec. 31, 2024
BALANCE SHEET COMPONENTS |
BALANCE SHEET COMPONENTS | (4) BALANCE SHEET COMPONENTS Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, | ​ | December 31, | ​
​ |  | 2024 |  | 2023 |
Other current assets | ​ | $ | 845 | ​ | $ | 250 | ​
Prepaid expenses | ​ | ​ | 649 | ​ | ​ | 1,168 | ​
Prepaid research and development | ​ | ​ | — | ​ | ​ | 375 | ​
Total prepaid expenses and other current assets | ​ | $ | 1,494 | ​ | $ | 1,793 | ​
​ Accrued and Other Current Liabilities In June 2024, following the Company’s decision to halt further development of AV-101, the Company announced its plan to terminate nearly all of its workforce in the coming months (the “Workforce Reduction Plan”). As of December 31, 2024, 47 individuals, or approximately 92% of the Company’s workforce, have been terminated. The affected individuals have been and will be provided severance benefits, including cash severance payments. Each affected individual’s eligibility for severance benefits is contingent upon entering into a separation agreement, which includes a general release of claims against the Company. In connection with the Workforce Reduction Plan, the Company incurred costs (in consideration of releases) of approximately $6.7 million, which are primarily one-time severance benefits, during the year ended December 31, 2024. The Company has paid approximately $3.8 million of severance benefits, and liabilities associated with the Workforce Reduction Plan were approximately $2.9 million as of December 31, 2024. The Company estimates that the remaining liabilities will be paid in the first quarter of 2025. Accrued and other current liabilities consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, | ​ | December 31, | ​
​ |  | 2024 |  | 2023 | ​
Accrued payroll and other employee benefits | ​ | ​ | 2,868 | ​ | ​ | 4,368 | ​
Other | ​ | ​ | 319 | ​ | ​ | 1,090 | ​
Accrued research and development | ​ | ​ | — | ​ | ​ | 9,363 | ​
Total accrued and other current liabilities | ​ | $ | 3,187 | ​ | $ | 14,821 | ​
​

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration